Chr. Hansen
在场
Chr. Hansen 的所有者是 Novozymes.
是其中之一......
Novozymes 是一家在股票代码 NVZMY (DK) 下上市的公司。
他们在：
涉及Novozymes的并购和融资。
- Novozymes and Chr. Hansen have merged (公布2024一月29号)..
高管
查看带有其 18 名主要高管的组织结构图
Chr. Hansen 搜索最多的简介
- Kim Soerensen, Director, Employee Representative
- Casper Lynghøj Giedo, Director, Employee Representative
- Charlotte Hemmingsen, Director, Employee Representative
高管在Chr. Hansen变化
- Mauricio Graber, President and Chief Executive Officer, 已经离开公司 (新闻发布的2024三月5号).
高管在Novozymes变化
- Kevin Lane已作为Director加入公司 (新闻发布的2024三月5号).
- Lise Kaae已作为Director加入公司 (新闻发布的2024三月5号).
- Jesper Brandgaard已作为Vice Chairman of the Board加入公司 (新闻发布的2024三月5号).
创建提醒
跟踪 Chr. Hansen 的高管变动
化学
Novozymes 拥有 1,038 家竞争者，其中包括 BASF (德国)、AkzoNobel (荷兰) 和 Air Liquide (法国)。
Popular M&A news in 化学
- Piedmont Lithium and Sayona Mining have announced they will merge (公布2024十一月19号)..
- Rio Tinto has announced the acquisition of Arcadium Lithium (公布2024十月9号).
- Adnoc has announced the acquisition of Covestro (公布2024十月7号).
化学 行业的其他推荐联系人
消息
Chr. Hansen 的最新新闻稿
- Chr. Hansen reports solid results for Q3 with 9% organic growth
- Change of Management in Bacthera AG
- Chr. Hansen secures EU approval for the final HMO in its 5 HMO Mix
- Chr. Hansen reports strong results for Q2: 11% organic growth
- Chr. Hansen HMOs get Novel Food approval in EU
- Chr. Hansen reports 10% organic growth for first quarter of 2022/23
- CP Kelco and Chr. Hansen join forces to develop breakthrough, ambient, plant-based “vegurts”
- Chr. Hansen delivers 9% organic growth for 2021/22 despite volatile times
- Chr. Hansen HMO secures regulatory wins across geographies
- Chr. Hansen delivers 9% organic growth in Q3
- View more press releases Close
通过电子邮件
